{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T10:37:18Z","timestamp":1777718238067,"version":"3.51.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T00:00:00Z","timestamp":1567641600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T00:00:00Z","timestamp":1567641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"an Intelligent Synthetic Biology Center of the Global Frontier Project funded by the MSI","award":["2011-0031955"],"award-info":[{"award-number":["2011-0031955"]}]},{"name":"an Intelligent Synthetic Biology Center of the Global Frontier Project funded by the MSI","award":["2011-0031955"],"award-info":[{"award-number":["2011-0031955"]}]},{"name":"the project of the Global Ph.D. Fellowship from the National Research Foundation of Korea","award":["NRF-2014H1A2A1020081"],"award-info":[{"award-number":["NRF-2014H1A2A1020081"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Brain"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13041-019-0495-7","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T13:32:15Z","timestamp":1567776735000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Minor ginsenoside F1 improves memory in APP\/PS1 mice"],"prefix":"10.1186","volume":"12","author":[{"given":"Junho","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Pyo","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miran","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Hao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byeong-Min","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun-Chang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2139-5596","authenticated-orcid":false,"given":"Jin-Hee","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,5]]},"reference":[{"issue":"3","key":"495_CR1","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jalz.2018.02.001","volume":"14","author":"Alzheimer\u2019s Association","year":"2018","unstructured":"Alzheimer\u2019s Association. 2018 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2018;14(3):367\u2013429.","journal-title":"Alzheimers Dement"},{"key":"495_CR2","unstructured":"US Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). Early Alzheimer\u2019s disease: developing drugs for treatment\u2013guidance for industry 2018. \n                    https:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM596728.pdf\n                    \n                  . Accessed Feb 2018."},{"issue":"9","key":"495_CR3","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/jphp.12590","volume":"68","author":"L Yang","year":"2016","unstructured":"Yang L, Xin J, Zhang Z, Yan H, Wang J, Sun E, et al. TPGS-modified liposomes for the delivery of ginsenoside compound K against non-small cell lung cancer: formulation design and its evaluation in vitro and in vivo. J Pharm Pharmacol. 2016;68(9):1109\u201318.","journal-title":"J Pharm Pharmacol"},{"issue":"9","key":"495_CR4","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1248\/bpb.18.1197","volume":"18","author":"M Mochizuki","year":"1995","unstructured":"Mochizuki M, Yoo Y, Matsuzawa K, Sato K, Saiki I, Tonooka S, et al. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20 (R)-and 20 (S)-ginsenoside-Rg3, of red ginseng. Biol Pharm Bull. 1995;18(9):1197\u2013202.","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"495_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1745-7254.2005.00034.x","volume":"26","author":"Y Cheng","year":"2005","unstructured":"Cheng Y, SHEN LH, ZHANG JT. Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action. Acta Pharmacol Sin. 2005;26(2):143\u20139.","journal-title":"Acta Pharmacol Sin"},{"issue":"1\u20133","key":"495_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ejphar.2006.08.056","volume":"550","author":"WC Cho","year":"2006","unstructured":"Cho WC, Chung WS, Lee SK, Leung AW, Cheng CH, Yue KK. Ginsenoside re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats. Eur J Pharmacol. 2006;550(1\u20133):173\u20139.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"495_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059155","volume":"8","author":"Q Quan","year":"2013","unstructured":"Quan Q, Wang J, Li X, Wang Y. Ginsenoside Rg1 decreases A\u03b21\u201342 level by upregulating PPAR\u03b3 and IDE expression in the hippocampus of a rat model of Alzheimer's disease. PLoS One. 2013;8(3):e59155.","journal-title":"PLoS One"},{"issue":"3","key":"495_CR8","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/WAD.0b013e31816c92e6","volume":"22","author":"ST Lee","year":"2008","unstructured":"Lee ST, Chu K, Sim JY, Heo JH, Kim M. Panax ginseng enhances cognitive performance in Alzheimer disease. Alzheimer Dis Assoc Disord. 2008;22(3):222\u20136.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"4","key":"495_CR9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jgr.2017.12.008","volume":"42","author":"HJ Kim","year":"2018","unstructured":"Kim HJ, Jung SW, Kim SY, Cho IH, Kim HC, Rhim H, et al. Panax ginseng as an adjuvant treatment for Alzheimer's disease. Journal of ginseng research. 2018;42(4):401\u201311.","journal-title":"Journal of ginseng research"},{"issue":"5","key":"495_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/nure.12099","volume":"72","author":"I Smith","year":"2014","unstructured":"Smith I, Williamson EM, Putnam S, Farrimond J, Whalley BJ. Effects and mechanisms of ginseng and ginsenosides on cognition. Nutr Rev. 2014;72(5):319\u201333.","journal-title":"Nutr Rev"},{"issue":"11","key":"495_CR11","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0006-2952(99)00212-9","volume":"58","author":"AS Attele","year":"1999","unstructured":"Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol. 1999;58(11):1685\u201393.","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"495_CR12","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1124\/dmd.31.8.1065","volume":"31","author":"MA Tawab","year":"2003","unstructured":"Tawab MA, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M. Degradation of ginsenosides in humans after oral administration. Drug Metab Dispos. 2003;31(8):1065\u201371.","journal-title":"Drug Metab Dispos"},{"key":"495_CR13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1254\/jphs.FMJ04001X4","volume":"95","author":"H Hasegawa","year":"2004","unstructured":"Hasegawa H. Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid. J Pharmacol Sci. 2004;95:153\u20137.","journal-title":"J Pharmacol Sci"},{"issue":"9","key":"495_CR14","doi-asserted-by":"publisher","first-page":"5770","DOI":"10.1021\/jf1005885","volume":"58","author":"JQ Ruan","year":"2010","unstructured":"Ruan JQ, Leong WI, Yan R, Wang YT. Characterization of metabolism and in vitro permeability study of notoginsenoside R1 from Radix notoginseng. J Agric Food Chem. 2010;58(9):5770\u20136.","journal-title":"J Agric Food Chem"},{"issue":"12","key":"495_CR15","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1007\/s12272-010-1213-2","volume":"33","author":"L Feng","year":"2010","unstructured":"Feng L, Wang L, Hu C, Jiang X. Pharmacokinetics, tissue distribution, metabolism, and excretion of ginsenoside Rg 1 in rats. Arch Pharm Res. 2010;33(12):1975\u201384.","journal-title":"Arch Pharm Res"},{"issue":"12","key":"495_CR16","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1124\/dmd.109.029819","volume":"37","author":"H Liu","year":"2009","unstructured":"Liu H, Yang J, Du F, Gao X, Ma X, Huang Y, et al. Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats. Drug Metab Dispos. 2009;37(12):2290\u20138.","journal-title":"Drug Metab Dispos"},{"issue":"10","key":"495_CR17","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1248\/bpb.28.1903","volume":"28","author":"EA Bae","year":"2005","unstructured":"Bae EA, Shin JE, Kim DH. Metabolism of ginsenoside re by human intestinal microflora and its estrogenic effect. Biol Pharm Bull. 2005;28(10):1903\u20138.","journal-title":"Biol Pharm Bull"},{"issue":"6","key":"495_CR18","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/jnr.1045","volume":"63","author":"I Mook-Jung","year":"2001","unstructured":"Mook-Jung I, Hong HS, Boo JH, Lee KH, Yun SH, Cheong MY, et al. Ginsenoside Rb1 and Rg1 improve spatial learning and increase hippocampal synaptophysin level in mice. J Neurosci Res. 2001;63(6):509\u201315.","journal-title":"J Neurosci Res"},{"issue":"2","key":"495_CR19","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.bbadis.2011.10.004","volume":"1822","author":"F Fang","year":"2012","unstructured":"Fang F, Chen X, Huang T, Lue LF, Luddy JS, Yan SS. Multi-faced neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse model. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2012;1822(2):286\u201392.","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"key":"495_CR20","first-page":"54","volume":"985","author":"N Li","year":"2015","unstructured":"Li N, Zhou L, Li W, Liu Y, Wang J, He P. Protective effects of ginsenosides Rg1 and Rb1 on an Alzheimer's disease mouse model: a metabolomics study. J Chromatogr. 2015;985:54\u201361.","journal-title":"J Chromatogr"},{"issue":"3","key":"495_CR21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jbiotec.2012.06.021","volume":"161","author":"JK Kim","year":"2012","unstructured":"Kim JK, Cui CH, Yoon MH, Kim SC, Im WT. Bioconversion of major ginsenosides Rg1 to minor ginsenoside F1 using novel recombinant ginsenoside hydrolyzing glycosidase cloned from Sanguibacter keddieii and enzyme characterization. J Biotechnol. 2012;161(3):294\u2013301.","journal-title":"J Biotechnol"},{"issue":"7","key":"495_CR22","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.neurobiolaging.2003.09.008","volume":"25","author":"JL Jankowsky","year":"2004","unstructured":"Jankowsky JL, Slunt HH, Gonzales V, Jenkins NA, Copeland NG, Borchelt DR. APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1. Neurobiol Aging. 2004;25(7):885\u201392.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"495_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/hmg\/ddh019","volume":"13","author":"JL Jankowsky","year":"2003","unstructured":"Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, et al. Mutant presenilins specifically elevate the levels of the 42 residue \u03b2-amyloid peptide in vivo: evidence for augmentation of a 42-specific \u03b3 secretase. Hum Mol Genet. 2003;13(2):159\u201370.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"495_CR24","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3233\/JAD-160572","volume":"54","author":"L Ordonez-Gutierrez","year":"2016","unstructured":"Ordonez-Gutierrez L, Fernandez-Perez I, Herrera JL, Anton M, Benito-Cuesta I, Wandosell F. A\u03b2PP\/PS1 transgenic mice show sex differences in the cerebellum associated with aging. J Alzheimers Dis. 2016;54(2):645\u201356.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"495_CR25","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3233\/JAD-141158","volume":"44","author":"L Ord\u00f3\u00f1ez-Guti\u00e9rrez","year":"2015","unstructured":"Ord\u00f3\u00f1ez-Guti\u00e9rrez L, Ant\u00f3n M, Wandosell F. Peripheral amyloid levels present gender differences associated with aging in A\u03b2PP\/PS1 mice. J Alzheimers Dis. 2015;44(4):1063\u20138.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"495_CR26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1601-183X.2006.00221.x","volume":"6","author":"RS Reiserer","year":"2007","unstructured":"Reiserer RS, Harrison FE, Syverud DC, McDonald MP. Impaired spatial learning in the APPSwe+ PSEN1\u0394E9 bigenic mouse model of Alzheimer\u2019s disease. Genes Brain Behav. 2007;6(1):54\u201365.","journal-title":"Genes Brain Behav"},{"key":"495_CR27","doi-asserted-by":"publisher","first-page":"7467","DOI":"10.1038\/srep07467","volume":"4","author":"HY Kim","year":"2014","unstructured":"Kim HY, Kim HV, Yoon JH, Kang BR, Cho SM, Lee S, et al. Taurine in drinking water recovers learning and memory in the adult APP\/PS1 mouse model of Alzheimer's disease. Sci Rep. 2014;4:7467.","journal-title":"Sci Rep"},{"issue":"3","key":"495_CR28","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.nbd.2004.10.022","volume":"18","author":"A Savonenko","year":"2005","unstructured":"Savonenko A, Xu GM, Melnikova T, Morton JL, Gonzales V, Wong MP, et al. Episodic-like memory deficits in the APPswe\/PS1dE9 mouse model of Alzheimer's disease: relationships to \u03b2-amyloid deposition and neurotransmitter abnormalities. Neurobiol Dis. 2005;18(3):602\u201317.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"495_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0149-7634(01)00041-0","volume":"26","author":"R Lalonde","year":"2002","unstructured":"Lalonde R. The neurobiological basis of spontaneous alternation. Neurosci Biobehav Rev. 2002;26(1):91\u2013104.","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"495_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3758\/BF03326820","volume":"3","author":"I Divac","year":"1975","unstructured":"Divac I, Wikmark RGE, Gade A. Spontaneous alternation in rats with lesions in the frontal lobes: an extension of the frontal lobe syndrome. Physiol Psychol. 1975;3(1):39\u201342.","journal-title":"Physiol Psychol"},{"issue":"6","key":"495_CR31","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1037\/0735-7044.110.6.1282","volume":"110","author":"B Delatour","year":"1996","unstructured":"Delatour B, Gisquet-Verrier P. Prelimbic cortex specific lesions disrupt delayed-variable response tasks in the rat. Behav Neurosci. 1996;110(6):1282.","journal-title":"Behav Neurosci"},{"issue":"2","key":"495_CR32","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1037\/0735-7044.106.2.274","volume":"106","author":"R Phillips","year":"1992","unstructured":"Phillips R, LeDoux JE. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci. 1992;106(2):274.","journal-title":"Behav Neurosci"},{"issue":"8","key":"495_CR33","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/S0028-3932(01)00223-8","volume":"40","author":"S Hamann","year":"2002","unstructured":"Hamann S, Monarch ES, Goldstein FC. Impaired fear conditioning in Alzheimer\u2019s disease. Neuropsychologia. 2002;40(8):1187\u201395.","journal-title":"Neuropsychologia."},{"key":"495_CR34","doi-asserted-by":"publisher","first-page":"8997","DOI":"10.1038\/ncomms9997","volume":"6","author":"HY Kim","year":"2015","unstructured":"Kim HY, Kim HV, Jo S, Lee CJ, Choi SY, Kim DJ, Kim Y. EPPS rescues hippocampus-dependent cognitive deficits in APP\/PS1 mice by disaggregation of amyloid-\u03b2 oligomers and plaques. Nat Commun. 2015;6:8997.","journal-title":"Nat Commun"},{"issue":"6075","key":"495_CR35","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1126\/science.1217697","volume":"335","author":"PE Cramer","year":"2012","unstructured":"Cramer PE, Cirrito JR, Wesson DW, Lee CD, Karlo JC, Zinn AE, et al. ApoE-directed therapeutics rapidly clear \u03b2 amyloid and reverse deficits in AD mouse models. Science. 2012;335(6075):1503\u20136.","journal-title":"Science."},{"issue":"6","key":"495_CR36","doi-asserted-by":"publisher","first-page":"a006262","DOI":"10.1101\/cshperspect.a006262","volume":"2","author":"CL Masters","year":"2012","unstructured":"Masters CL, Selkoe DJ. Biochemistry of amyloid \u03b2-protein and amyloid deposits in Alzheimer disease. Cold Spring Harbor perspectives in medicine. 2012;2(6):a006262.","journal-title":"Cold Spring Harbor perspectives in medicine"},{"issue":"4916","key":"495_CR37","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1126\/science.2474201","volume":"245","author":"BA Yankner","year":"1989","unstructured":"Yankner BA, Dawes LR, Fisher S, Villa-Komaroff L, Oster-Granite ML, Neve RL. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science. 1989;245(4916):417\u201320.","journal-title":"Science."},{"issue":"11","key":"495_CR38","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/nrn2733","volume":"10","author":"SD Vann","year":"2009","unstructured":"Vann SD, Aggleton JP, Maguire EA. What does the retrosplenial cortex do? Nat Rev Neurosci. 2009;10(11):792.","journal-title":"Nat Rev Neurosci"},{"key":"495_CR39","unstructured":"Paxinos G, Franklin BJ. The Mouse Brain in Stereotaxic Coordinates. 2nd ed. Academic Press;2001."},{"issue":"1","key":"495_CR40","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1750-1326-6-60","volume":"6","author":"S Pugazhenthi","year":"2011","unstructured":"Pugazhenthi S, Wang M, Pham S, Sze CI, Eckman CB. Downregulation of CREB expression in Alzheimer's brain and in A\u03b2-treated rat hippocampal neurons. Mol Neurodegener. 2011;6(1):60.","journal-title":"Mol Neurodegener"},{"issue":"9","key":"495_CR41","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/mp.2016.111","volume":"21","author":"N Bartolotti","year":"2016","unstructured":"Bartolotti N, Bennett DA, Lazarov O. Reduced pCREB in Alzheimer\u2019s disease prefrontal cortex is reflected in peripheral blood mononuclear cells. Mol Psychiatry. 2016;21(9):1158.","journal-title":"Mol Psychiatry"},{"issue":"6","key":"495_CR42","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.neuropharm.2009.11.002","volume":"58","author":"Y Hou","year":"2010","unstructured":"Hou Y, Aboukhatwa MA, Lei DL, Manaye K, Khan I, Luo Y. Anti-depressant natural flavonols modulate BDNF and beta amyloid in neurons and hippocampus of double TgAD mice. Neuropharmacology. 2010;58(6):911\u201320.","journal-title":"Neuropharmacology."},{"key":"495_CR43","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.bbr.2013.05.017","volume":"250","author":"J Zhang","year":"2013","unstructured":"Zhang J, Guo J, Zhao X, Chen Z, Wang G, Liu A. Phosphodiesterase-5 inhibitor sildenafil prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in APP\/PS1 transgenic mice. Behav Brain Res. 2013;250:230\u20137.","journal-title":"Behav Brain Res"},{"key":"495_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2011.05.056","volume":"1403","author":"HC Ke","year":"2011","unstructured":"Ke HC, Huang HJ, Liang KC, Hsieh-Li HM. Selective improvement of cognitive function in adult and aged APP\/PS1 transgenic mice by continuous non-shock treadmill exercise. Brain Res. 2011;1403:1\u201311.","journal-title":"Brain Res"},{"issue":"52","key":"495_CR45","doi-asserted-by":"publisher","first-page":"22687","DOI":"10.1073\/pnas.1012851108","volume":"107","author":"A Caccamo","year":"2010","unstructured":"Caccamo A, Maldonado MA, Bokov AF, Majumder S, Oddo S. CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A. 2010;107(52):22687\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"495_CR46","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/0896-6273(91)90273-3","volume":"7","author":"HS Phillips","year":"1991","unstructured":"Phillips HS, Hains JM, Armanini M, Laramee GR, Johnson SA, Winslow JW. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron. 1991;7(5):695\u2013702.","journal-title":"Neuron."},{"issue":"6","key":"495_CR47","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1111\/j.1471-4159.2005.03135.x","volume":"93","author":"S Peng","year":"2005","unstructured":"Peng S, Wuu J, Mufson EJ, Fahnestock M. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. J Neurochem. 2005;93(6):1412\u201321.","journal-title":"J Neurochem"},{"issue":"32","key":"495_CR48","doi-asserted-by":"publisher","first-page":"13594","DOI":"10.1073\/pnas.0901402106","volume":"106","author":"M Blurton-Jones","year":"2009","unstructured":"Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castello NA, M\u00fcller FJ, Loring JF, et al. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci U S A. 2009;106(32):13594\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"495_CR49","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nm.1912","volume":"15","author":"AH Nagahara","year":"2009","unstructured":"Nagahara AH, Merrill DA, Coppola G, Tsukada S, Schroeder BE, Shaked GM, et al. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med. 2009;15(3):331.","journal-title":"Nat Med"},{"issue":"5","key":"495_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064460","volume":"8","author":"YS Hu","year":"2013","unstructured":"Hu YS, Long N, Pigino G, Brady ST, Lazarov O. Molecular mechanisms of environmental enrichment: impairments in Akt\/GSK3\u03b2, neurotrophin-3 and CREB signaling. PLoS One. 2013;8(5):e64460.","journal-title":"PLoS One"},{"issue":"4","key":"495_CR51","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0896-6273(00)81010-7","volume":"20","author":"X Tao","year":"1998","unstructured":"Tao X, Finkbeiner S, Arnold DB, Shaywitz AJ, Greenberg ME. Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron. 1998;20(4):709\u201326.","journal-title":"Neuron."},{"issue":"2","key":"495_CR52","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1515\/rns.2011.018","volume":"22","author":"CA Saura","year":"2011","unstructured":"Saura CA, Valero J. The role of CREB signaling in Alzheimer\u2019s disease and other cognitive disorders. Rev Neurosci. 2011;22(2):153\u201369.","journal-title":"Rev Neurosci"},{"issue":"22","key":"495_CR53","doi-asserted-by":"publisher","first-page":"7453","DOI":"10.1523\/JNEUROSCI.3997-09.2010","volume":"30","author":"KA McDowell","year":"2010","unstructured":"McDowell KA, Hutchinson AN, Wong-Goodrich SJ, Presby MM, Su D, Rodriguiz RM, et al. Reduced cortical BDNF expression and aberrant memory in Carf knock-out mice. J Neurosci. 2010;30(22):7453\u201365.","journal-title":"J Neurosci"},{"issue":"3","key":"495_CR54","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/0896-6273(93)90335-O","volume":"10","author":"T Timmusk","year":"1993","unstructured":"Timmusk T, Palm K, Metsis M, Reintam T, Paalme V, Saarma M, Persson H. Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron. 1993;10(3):475\u201389.","journal-title":"Neuron."},{"issue":"7","key":"495_CR55","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1523\/JNEUROSCI.23-07-02572.2003","volume":"23","author":"WG Chen","year":"2003","unstructured":"Chen WG, West AE, Tao X, Corfas G, Szentirmay MN, Sawadogo M, et al. Upstream stimulatory factors are mediators of Ca2+\u2212responsive transcription in neurons. J Neurosci. 2003;23(7):2572\u201381.","journal-title":"J Neurosci"},{"issue":"6","key":"495_CR56","doi-asserted-by":"publisher","first-page":"4904","DOI":"10.3892\/mmr.2016.5103","volume":"13","author":"F Li","year":"2016","unstructured":"Li F, Wu X, Li J, Niu Q. Ginsenoside Rg1 ameliorates hippocampal long-term potentiation and memory in an Alzheimer's disease model. Mol Med Rep. 2016;13(6):4904\u201310.","journal-title":"Mol Med Rep"},{"issue":"3","key":"495_CR57","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3233\/JAD-2010-1296","volume":"19","author":"YQ Shi","year":"2010","unstructured":"Shi YQ, Huang TW, Chen LM, Pan XD, Zhang J, Zhu YG, Chen XC. Ginsenoside Rg1 attenuates amyloid-\u03b2 content, regulates PKA\/CREB activity, and improves cognitive performance in SAMP8 mice. J Alzheimers Dis. 2010;19(3):977\u201389.","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"495_CR58","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1463-1326.2009.01193.x","volume":"12","author":"L Zhang","year":"2010","unstructured":"Zhang L, Lee NJ, Nguyen AD, Enriquez RF, Riepler SJ, Stehrer B, et al. Additive actions of the cannabinoid and neuropeptide Y systems on adiposity and lipid oxidation. Diabetes Obes Metab. 2010;12(7):591\u2013603.","journal-title":"Diabetes Obes Metab"},{"key":"495_CR59","doi-asserted-by":"crossref","unstructured":"Zhang L. Voluntary oral administration of drugs in mice. Protocol Exchange. 2011;10.","DOI":"10.1038\/protex.2011.236"}],"container-title":["Molecular Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-019-0495-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13041-019-0495-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-019-0495-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T23:19:38Z","timestamp":1599175178000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularbrain.biomedcentral.com\/articles\/10.1186\/s13041-019-0495-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,5]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["495"],"URL":"https:\/\/doi.org\/10.1186\/s13041-019-0495-7","relation":{},"ISSN":["1756-6606"],"issn-type":[{"value":"1756-6606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,5]]},"assertion":[{"value":"4 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures and protocols were approved by the Animal Ethics Committee at the Korea Advanced Institute of Science and Technology. All experiments were performed in accordance with the guideline of Institutional Animal Care and Use Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}